OBJECTIVE: To study health care utilization patterns in patients with gout. METHODS: In a gout population from primary care and rheumatology clinics in 3 U.S. metropolitan cities, we collected data on gout-related utilization (primary care, rheumatology, urgent care, emergency room, and other) in the past year. We evaluated the association of comorbidities, age, gender, gout characteristics (time since last gout attack and tophi), and gout severity ratings (mean of serum uric acid, patient-rated, and physician-rated gout severity) and with emergency/urgent care and primary care utilization using regression and correlation analyses. RESULTS: Of the 296 patients who reported visiting at least 1 type of health practitioner for gout in the past year, the percentage of patients utilizing the service at least once and annual utilization rates among utilizers were as follows: primary care physician, 60%, 3.0 ± 3.4; nurse practitioner/physician assistant, 26%, 2.7 ± 2.5; rheumatologist, 51%, 3.7 ± 5.7; urgent care, 23%, 2.1 ± 2.2; emergency room, 20%, 2.0 ± 1.7; and hospitalization, 7%, 2.1 ± 1.4. Higher overall gout severity was associated with greater use of each resource type and with overall gout-related utilization. Nonemergency/nonurgent care utilization (primary care physician, nurse practitioner, physician's assistant, and rheumatologist for gout) was the strongest predictor of gout-related emergency/urgent care utilization. Patients with more comorbidities had greater gout-related primary care utilization. CONCLUSIONS: Overall gout severity was associated with all types of gout-related utilization. This may help to screen high utilizers for targeted behavioral and therapeutic interventions. Having a higher number of comorbid conditions was a risk factor for higher gout-related primary care utilization. Published by Elsevier Inc.
OBJECTIVE: To study health care utilization patterns in patients with gout. METHODS: In a gout population from primary care and rheumatology clinics in 3 U.S. metropolitan cities, we collected data on gout-related utilization (primary care, rheumatology, urgent care, emergency room, and other) in the past year. We evaluated the association of comorbidities, age, gender, gout characteristics (time since last gout attack and tophi), and gout severity ratings (mean of serum uric acid, patient-rated, and physician-rated gout severity) and with emergency/urgent care and primary care utilization using regression and correlation analyses. RESULTS: Of the 296 patients who reported visiting at least 1 type of health practitioner for gout in the past year, the percentage of patients utilizing the service at least once and annual utilization rates among utilizers were as follows: primary care physician, 60%, 3.0 ± 3.4; nurse practitioner/physician assistant, 26%, 2.7 ± 2.5; rheumatologist, 51%, 3.7 ± 5.7; urgent care, 23%, 2.1 ± 2.2; emergency room, 20%, 2.0 ± 1.7; and hospitalization, 7%, 2.1 ± 1.4. Higher overall gout severity was associated with greater use of each resource type and with overall gout-related utilization. Nonemergency/nonurgent care utilization (primary care physician, nurse practitioner, physician's assistant, and rheumatologist for gout) was the strongest predictor of gout-related emergency/urgent care utilization. Patients with more comorbidities had greater gout-related primary care utilization. CONCLUSIONS: Overall gout severity was associated with all types of gout-related utilization. This may help to screen high utilizers for targeted behavioral and therapeutic interventions. Having a higher number of comorbid conditions was a risk factor for higher gout-related primary care utilization. Published by Elsevier Inc.
Authors: Emvalee Arromdee; Clement J Michet; Cynthia S Crowson; W Michael O'Fallon; Sherine E Gabriel Journal: J Rheumatol Date: 2002-11 Impact factor: 4.666
Authors: John G Hanly; Chris Skedgel; Ingrid Sketris; Charmaine Cooke; Tina Linehan; Kara Thompson; Sander Veldhuyzen van Zanten Journal: J Rheumatol Date: 2009-03-13 Impact factor: 4.666
Authors: Jan D Hirsch; Susan J Lee; Robert Terkeltaub; Dinesh Khanna; Jasvinder Singh; Andrew Sarkin; Jodi Harvey; Arthur Kavanaugh Journal: J Rheumatol Date: 2008-10-15 Impact factor: 4.666
Authors: Karen L Margolis; Robert Brzyski; Denise E Bonds; Barbara V Howard; Sarah Kempainen; Jennifer G Robinson; Monika M Safford; Lesley T Tinker; Lawrence S Phillips Journal: Clin Trials Date: 2008 Impact factor: 2.486
Authors: Robert Morlock; Pierre Chevalier; Laura Horne; Javier Nuevo; Chris Storgard; Lalitha Aiyer; Dionne M Hines; Xavier Ansolabehere; Fredrik Nyberg Journal: Rheumatol Ther Date: 2016-05-25
Authors: Irvin J Huang; Jean W Liew; Meredith B Morcos; Silu Zuo; Carol Crawford; Alison M Bays Journal: Rheumatol Int Date: 2019-05-30 Impact factor: 2.631
Authors: Seoyoung C Kim; Bernhard M W Schmidt; Jessica M Franklin; Jun Liu; Daniel H Solomon; Sebastian Schneeweiss Journal: Arthritis Care Res (Hoboken) Date: 2013-12 Impact factor: 4.794
Authors: Puja P Khanna; George Nuki; Thomas Bardin; Anne-Kathrin Tausche; Anna Forsythe; Amir Goren; Jeffrey Vietri; Dinesh Khanna Journal: Health Qual Life Outcomes Date: 2012-09-22 Impact factor: 3.186
Authors: Naomi Schlesinger; Diane C Radvanski; Tina C Young; Jonathan V McCoy; Robert Eisenstein; Dirk F Moore Journal: Open Rheumatol J Date: 2015-06-12
Authors: Robert A Terkeltaub; H Ralph Schumacher; John D Carter; Herbert S B Baraf; Robert R Evans; Jian Wang; Shirletta King-Davis; Steven P Weinstein Journal: Arthritis Res Ther Date: 2013-02-01 Impact factor: 5.156